1-9 of 9
Rongrong Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Outcomes of Stem Cell Transplant in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents: Experience from Routine Clinical Practices in the United States

Kimo Bachiashvili, Esprit Ma, Achal Patel, Rongrong Wang, Archibong Yellow-Duke, Melissa Montez, Cat N. Bui, Sarah Worth, Pankit Vachhani
Journal: Blood
Blood (2023) 142 (Supplement 1): 7415.
https://doi.org/10.1182/blood-2023-178008
Published: 2023
Journal Articles

The Cytogenetic and Molecular Testing Landscape in Patients with Newly Diagnosed Acute Myeloid Leukemia in Routine Clinical Practices in the United States

Kimo Bachiashvili, Shuko Harada, Esprit Ma, Achal Patel, Rongrong Wang, Archibong Yellow-Duke, Melissa Montez, Vivek Chopra, Cat N. Bui, Pankit Vachhani
Journal: Blood
Blood (2023) 142 (Supplement 1): 2436.
https://doi.org/10.1182/blood-2023-179370
Published: 2023
Journal Articles

Unmet Medical Needs Amongst Older Patients Aged ≥60 Years with Newly Diagnosed Acute Myeloid Leukemia Receiving Intensive Chemotherapy: Experience from a Predominately United States Community Setting

Tapan M. Kadia, Alex Bataller, Esprit Ma, Achal Patel, Rongrong Wang, Archibong Yellow-Duke, Melissa Montez, Cat N. Bui, Farhad Ravandi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3814.
https://doi.org/10.1182/blood-2023-178004
Published: 2023
Journal Articles

Real-World Assessment of Second Primary Malignancies in a Treated and Untreated Chronic Lymphocytic Leukemia Population in the United States

Sikander Ailawadhi, Arliene Ravelo, Carmen Ng, Bonny Shah, Rongrong Wang, Katherine Eakle, Juliana Biondo
Journal: Blood
Blood (2022) 140 (Supplement 1): 8040–8041.
https://doi.org/10.1182/blood-2022-158139
Published: 2022
Journal Articles

Cost of Disease Progression after Frontline (1L) R-CHOP in Diffuse Large B-Cell Lymphoma (DLBCL)

Rongrong Wang, Josh Roth, Carmen Ng, Farah Hossain, Jia Li, Anthony Masaquel
Journal: Blood
Blood (2021) 138 (Supplement 1): 3002.
https://doi.org/10.1182/blood-2021-146802
Published: 2021
Journal Articles

Healthcare Resource Utilization and Costs Associated with Obinutuzumab Plus Bendamustine Versus Rituximab Plus Bendamustine for First-Line Treatment of Follicular Lymphoma

Tu My To, Jamie T. Ta, Arpamas Seetasith, Rongrong Wang, Dominic Lai, Sheila Shapouri
Journal: Blood
Blood (2021) 138 (Supplement 1): 3004.
https://doi.org/10.1182/blood-2021-145607
Published: 2021
Journal Articles

Healthcare Resource Utilization and Costs of Patients with Relapsed/Refractory Follicular Lymphoma Receiving 3 or More Lines of Therapy

Matthew J. Matasar, Sheila Shapouri, Jamie T. Ta, Tu My To, Mei Wu, Rongrong Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1923.
https://doi.org/10.1182/blood-2021-145407
Published: 2021
Journal Articles

Real-World Persistence with and Adherence to Emicizumab Prophylaxis in Persons with Hemophilia a: A Secondary Claims Database Analysis

Arash Mahajerin, Rahul Khairnar, Craig S. Meyer, Ibrahim M. Abbass, Rongrong Wang, Lucy Lee, Eunice Tzeng, Karina Raimundo
Journal: Blood
Blood (2020) 136 (Supplement 1): 13.
https://doi.org/10.1182/blood-2020-137632
Published: 2020
Journal Articles

Idelalisib for Treatment of Follicular Lymphoma and Chronic Lymphocytic Leukemia in Clinical Trials Versus the Real World: Treatment Duration and Survival Are Associated with Pretreatment Modified Charlson Score

Steven T Bird, PhD PharmD, Natasha Flowers, BA, Fang Tian, PhD MHS, MPH, Donna Przepiorka, MD PhD, Tae Hyun Jung, PhD, Rongrong Wang, MPH, Zebulin Kessler, BS, Corinne Woods, RPh, MPH, Bo Kim, BA, Barry W. Miller, MS, CNP, Michael Wernecke, BA, Stephen McKean, PhD, Clara Kim, PhD, Kate Gelperin, MD MPH, Jeffrey A Kelman, MD MMSc, David J Graham, MD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 2889.
https://doi.org/10.1182/blood-2018-99-116498
Published: 2018